Company Filing History:
Years Active: 2015-2019
Title: Hiroaki Tasaki: Innovator in Pharmaceutical Composition
Introduction
Hiroaki Tasaki, based in Tokyo, Japan, is a distinguished inventor known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of four patents, his work primarily focuses on developing stabilized pharmaceutical compositions.
Latest Patents
Among his latest innovative contributions are two notable patents. The first patent details a stabilized pharmaceutical composition comprising a specific compound, 5-{[(3R)-1-acryloylpyrrolidin-3-yl]oxy}-6-ethyl-3-({4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}amino)-pyrazine-2-carboxamide, also referred to as 'compound A'. This composition includes a pharmaceutical additive with a water activity value difference of 0.1 or more, contributing to its stabilization. The second patent presents a unique pharmaceutical composition that utilizes a complex between solifenacin, a pharmaceutically acceptable salt thereof, and an ion exchange resin, combined with an acrylic-based polymer.
Career Highlights
Hiroaki Tasaki has established a notable career at Astellas Pharma GmbH, where he continues to innovate and develop advanced pharmaceutical solutions. His expertise in pharmaceutical chemistry is complemented by his commitment to improving drug stability and efficacy for better patient outcomes.
Collaborations
Throughout his career, Hiroaki has collaborated with skilled professionals, including his coworkers Mitsuru Yoshida and Daisuke Tsunashima. These collaborations have played a vital role in enhancing the quality and scope of the pharmaceutical innovations he has brought to life.
Conclusion
Hiroaki Tasaki stands out as a prolific inventor in the pharmaceutical industry, with a focus on creating stabilized compositions that address critical medical needs. His ongoing work at Astellas Pharma GmbH continues to pave the way for future advancements in pharmaceutical innovation.